EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Ferritin, inflammation, and iron deficiency in acute heart failure: evidence from the EDIFICA cohort

Ferritin, Entzündung und Eisenmangel bei akuter Herzinsuffizienz: Evidenz aus der EDIFICA-Kohorte

Francisco Vasques-Nóvoa, Maria João Pimentel, Pedro Marques, Catarina Vale, Filipa Gomes, João Sérgio Neves, Isaac Barroso, João Tiago Guimarães, Paulo Bettencourt, Adelino F Leite-Moreira, Roberto Roncon-Albuquerque, Jorge Almeida und 2 weitere

Clinical Research in Cardiology · 2026-11 · 115 (11) · 1889-1896

DOI: 10.1007/s00392-024-02535-x ↗

Auf einen Blick

Bei 526 Patient:innen mit akuter Herzinsuffizienz war höheres Ferritin bei Aufnahme mit schlechterer Prognose assoziiert. Niedriges Ferritin war mit einem günstigeren Verlauf verbunden.

Fragestellung

Welche klinischen und prognostischen Zusammenhänge bestehen zwischen Ferritinwerten und den Folgen einer akuten Herzinsuffizienz, und wird dies durch Infektion, Entzündung oder Eisenmangelmarker beeinflusst?

Methode

Kohortenstudie aus dem EDIFICA-Register mit 526 Patient:innen; Analyse der Assoziation zwischen Ferritin und klinischen Outcomes über 180 Tage.

Ergebnisse

Medianes Ferritin bei Aufnahme 180 pg/mL. Höhere Ferritinwerte waren mit einem erhöhten Risiko für Hospitalisierung wegen Herzinsuffizienz oder kardiovaskulären Tod assoziiert: Tertil 2 HR 1,75 (95 %-KI 1,10–2,79), Tertil 3 HR 1,79 (95 %-KI 1,08–2,97).

Schlussfolgerung der Autor:innen

Erhöhte Ferritinwerte sind bei akuter Herzinsuffizienz unabhängig mit einer ungünstigen Prognose assoziiert. Niedrige Ferritinwerte sind mit einem günstigeren Verlauf verbunden und sind in dieser Population kein verlässlicher Marker für ID.

Kernaussagen

  • 526 Patient:innen aus dem EDIFICA-Register
  • Höheres Ferritin: höheres Risiko für Herzinsuffizienz-Hospitalisierung oder kardiovaskulären Tod
  • Serum-Eisen, Transferrinsättigung und ID-Kriterien zeigten keine signifikante Assoziation bei Aufnahme

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Research in Cardiology, online erschienen am 19.09.2024. Verfasst von Francisco Vasques-Nóvoa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Centro Hospitalar Universitário de São João, Porto, Portugal. fvasquesnovoa@med.up.pt. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Ferritins, Heart Failure, Inflammation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, Universidade do Porto.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ferritin is commonly used to evaluate iron stores and guide therapeutic decisions regarding intravenous iron supplementation. However, in the context of AHF, inflammation-driven upregulation of ferritin might disrupt its correlation with iron stores, restricting iron bioavailability and potentially amplifying the inflammatory response.

Aim

This study aims to assess the clinical and prognostic associations of ferritin levels in an AHF cohort and to determine whether the prognostic value of ferritin is influenced by the presence of infection, inflammatory activation, and other markers of iron deficiency.

Methods

The association between ferritin and clinical outcomes (180 days) in AHF was evaluated in a cohort of 526 patients from the EDIFICA registry.

Results

The median ferritin plasma concentration at admission was 180 pg/mL. Patients with higher ferritin levels at admission were predominantly men, exhibiting a high prevalence of chronic kidney disease and alcohol consumption, and presenting with lower blood pressure and a higher incidence of clinical infection. Higher ferritin levels were associated with increased risk of the composite of heart failure hospitalization or cardiovascular death (Tertile 2: HR 1.75; 95% CI 1.10–2.79; p = 0.017; Tertile 3: HR 1.79; 95% CI 1.08–2.97; p = 0.025), independently of classical HF prognostic factors, inflammatory and iron-related markers. No significant associations were found between admission serum iron or transferrin saturation tertiles, iron status categories, or guideline-defined iron deficiency (ID) criteria and the primary composite outcome. However, at discharge, patients who met the criteria for defective iron utilization, low iron storage, or guideline-defined ID had a lower risk of the composite endpoint compared to those with normal iron utilization or who did not meet the guideline-defined ID criteria, respectively.

Conclusions

Elevated ferritin levels are independently associated with poor prognosis in AHF. Low ferritin levels are associated with a favorable outcome and do not carry significant value in identifying ID in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Iron-DeficiencyFerritinsHeart FailureInflammationIron DeficienciesRegistriesAgedFemaleHumansMaleAcute DiseaseBiomarkersIronPrognosisRisk Factors

Stichwörter der Autor:innen

Acute heart failureFerritinInflammationIron deficiency

Substanzen

BiomarkersFerritinsIron

Autor:innen und Institutionen

  • Department of Internal Medicine, Centro Hospitalar Universitário de São João, Porto, Portugal. fvasquesnovoa@med.up.pt.
  • Cardiovascular Research and Development Center (UnIC@RISE), Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Alameda Hernâni Monteiro, 4200-319, Porto, Portugal. fvasquesnovoa@med.up…
  • Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal. fvasquesnovoa@med.up.pt.
  • Cardiovascular Research and Development Center (UnIC@RISE), Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Alameda Hernâni Monteiro, 4200-319, Porto, Portugal.
  • Department of Internal Medicine, Centro Hospitalar Universitário de São João, Porto, Portugal.
  • Department of Endocrinology, Centro Hospitalar Universitário de São João, Porto, Portugal.

Förderung

  • Fundação para a Ciência e a Tecnologia
  • Universidade do Porto

Zitieren

APA

Vasques-Nóvoa, F., Pimentel, M. J., Marques, P., Vale, C., Gomes, F., Neves, J. S., Barroso, I., Guimarães, J. T., Bettencourt, P., Leite-Moreira, A. F., Roncon-Albuquerque, R., Almeida, J., Ferreira, J. P., & Friões, F. (2026). Ferritin, inflammation, and iron deficiency in acute heart failure: evidence from the EDIFICA cohort. Clinical Research in Cardiology, 115(11), 1889-1896. https://doi.org/10.1007/s00392-024-02535-x

Vancouver

Vasques-Nóvoa F, Pimentel MJ, Marques P, Vale C, Gomes F, Neves JS, et al. Ferritin, inflammation, and iron deficiency in acute heart failure: evidence from the EDIFICA cohort. Clinical Research in Cardiology. 2026;115(11):1889-1896. doi:10.1007/s00392-024-02535-x

BibTeX
@article{VasquesNvoa2026,
  author = {Vasques-Nóvoa, Francisco and Pimentel, Maria João and Marques, Pedro and Vale, Catarina and Gomes, Filipa and Neves, João Sérgio and Barroso, Isaac and Guimarães, João Tiago and Bettencourt, Paulo and Leite-Moreira, Adelino F and Roncon-Albuquerque, Roberto and Almeida, Jorge and Ferreira, João Pedro and Friões, Fernando},
  title = {Ferritin, inflammation, and iron deficiency in acute heart failure: evidence from the EDIFICA cohort},
  journal = {Clinical Research in Cardiology},
  year = {2026},
  volume = {115},
  number = {11},
  pages = {1889--1896},
  doi = {10.1007/s00392-024-02535-x}
}
Kostenlos starten →